Mihui Li

434 total citations
18 papers, 331 citations indexed

About

Mihui Li is a scholar working on Physiology, Pharmacology and Immunology. According to data from OpenAlex, Mihui Li has authored 18 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 5 papers in Pharmacology and 5 papers in Immunology. Recurrent topics in Mihui Li's work include Asthma and respiratory diseases (5 papers), Flavonoids in Medical Research (4 papers) and Traditional Chinese Medicine Studies (3 papers). Mihui Li is often cited by papers focused on Asthma and respiratory diseases (5 papers), Flavonoids in Medical Research (4 papers) and Traditional Chinese Medicine Studies (3 papers). Mihui Li collaborates with scholars based in China, Thailand and Taiwan. Mihui Li's co-authors include Jingcheng Dong, Ying Wei, Jing Sun, Zhengxiao Zhao, Jiaqi Liu, Fei Xu, Qingli Luo, Linwei Lu, Hongying Zhang and Kai Wei and has published in prestigious journals such as Frontiers in Immunology, Biomedicine & Pharmacotherapy and Neuroscience Letters.

In The Last Decade

Mihui Li

18 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mihui Li China 13 130 86 68 65 57 18 331
Xuhua Yu China 14 158 1.2× 50 0.6× 96 1.4× 53 0.8× 48 0.8× 38 422
Ying‐Ling Chang Taiwan 12 171 1.3× 47 0.5× 60 0.9× 57 0.9× 58 1.0× 15 376
Jialei Fu China 9 171 1.3× 30 0.3× 54 0.8× 61 0.9× 23 0.4× 36 317
Sheikh Rayees India 12 187 1.4× 45 0.5× 41 0.6× 45 0.7× 102 1.8× 23 441
Liyue Qin China 6 196 1.5× 40 0.5× 45 0.7× 59 0.9× 29 0.5× 8 394
Tulake Wuniqiemu China 11 160 1.2× 27 0.3× 58 0.9× 109 1.7× 92 1.6× 16 416
Weidong Cheng China 7 187 1.4× 44 0.5× 24 0.4× 48 0.7× 34 0.6× 13 299
Xiaoqiang Geng China 11 196 1.5× 73 0.8× 31 0.5× 25 0.4× 23 0.4× 15 389
Shengyong Luo China 12 166 1.3× 35 0.4× 34 0.5× 23 0.4× 33 0.6× 20 389
Zeping Xie China 9 262 2.0× 46 0.5× 29 0.4× 74 1.1× 31 0.5× 15 451

Countries citing papers authored by Mihui Li

Since Specialization
Citations

This map shows the geographic impact of Mihui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihui Li more than expected).

Fields of papers citing papers by Mihui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihui Li. The network helps show where Mihui Li may publish in the future.

Co-authorship network of co-authors of Mihui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mihui Li. A scholar is included among the top collaborators of Mihui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihui Li. Mihui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gao, Zhen, Jingjing Qin, Wenqian Wang, et al.. (2023). Trends of therapy in the treatment of asthma. Therapeutic Advances in Respiratory Disease. 17. 2683735076–2683735076. 13 indexed citations
2.
Cui, Jie, Weifeng Tang, Wenqian Wang, et al.. (2023). Acteoside alleviates asthma by modulating ROS-responsive NF-κB/MAPK signaling pathway. International Immunopharmacology. 116. 109806–109806. 7 indexed citations
3.
Tang, Weifeng, Mihui Li, Fangzhou Teng, et al.. (2022). Single-cell RNA-sequencing in asthma research. Frontiers in Immunology. 13. 988573–988573. 16 indexed citations
4.
Dong, Ming, Weifeng Tang, Jingjing Qin, et al.. (2022). Ferroptosis, novel therapeutics in asthma. Biomedicine & Pharmacotherapy. 153. 113516–113516. 25 indexed citations
5.
Zhao, Zhengxiao, Baojun Liu, Jing Sun, et al.. (2019). Baicalein Inhibits Orthotopic Human Non-Small Cell Lung Cancer Xenografts via Src/Id1 Pathway. Evidence-based Complementary and Alternative Medicine. 2019. 1–7. 26 indexed citations
6.
Zhao, Zhengxiao, Baojun Liu, Jing Sun, et al.. (2019). Scutellaria Flavonoids Effectively Inhibit the Malignant Phenotypes of Non-small Cell Lung Cancer in an Id1-dependent Manner. International Journal of Biological Sciences. 15(7). 1500–1513. 38 indexed citations
7.
Kong, Qing, Rongrong Jiang, Mihui Li, et al.. (2019). A retrospective database analysis of traditional Chinese medicine syndromes in patients with chronic obstructive pulmonary disease and asthma. European Journal of Integrative Medicine. 32. 101001–101001. 3 indexed citations
8.
Zhao, Zhengxiao, Jingcheng Dong, Lumei Liu, et al.. (2019). Kidney-Qi deficiency diagnosed by Deng's diagnosis standard was not correlated with aging based on clinical observation of 90 participants.. PubMed. 39(2). 267–274. 1 indexed citations
9.
Dong, Ming, Juan Chen, Mihui Li, et al.. (2018). Acupuncture Regulates the Balance of CD4+ T Cell Subtypes in Experimental Asthma Mice. Chinese Journal of Integrative Medicine. 25(8). 617–624. 13 indexed citations
10.
Zhao, Zhengxiao, Weiyi Gong, Lumei Liu, et al.. (2018). Urinary 8-hydroxydeoxyguanosine is a better biomarker of aging in non-smokers. 1(1). 43–51. 2 indexed citations
11.
Xu, Fei, Wenqiang Cui, Zhengxiao Zhao, et al.. (2017). Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage‐Mediated Lung Cancer in Mice. Evidence-based Complementary and Alternative Medicine. 2017(1). 7187168–7187168. 18 indexed citations
12.
Wei, Kai, Weiqi Bao, Zhengxiao Zhao, et al.. (2017). Changes of the brain activities after chronic restraint stress in rats: A study based on 18F-FDG PET. Neuroscience Letters. 665. 104–109. 14 indexed citations
13.
Wei, Ying, Jiaqi Liu, Rungtip Soi‐ampornkul, et al.. (2017). Regulation of cytotoxicity and apoptosis-associated pathways contributes to the enhancement of efficacy of cisplatin by baicalein adjuvant in human A549 lung cancer cells. Oncology Letters. 13(4). 2799–2804. 19 indexed citations
14.
Li, Mihui, et al.. (2017). A Study of Traditional Chinese Medicine Body Constitution Associated with Overweight, Obesity, and Underweight. Evidence-based Complementary and Alternative Medicine. 2017(1). 28 indexed citations
15.
Liu, Jiaqi, Ying Wei, Qingli Luo, et al.. (2016). Baicalin attenuates inflammation in mice with OVA-induced asthma by inhibiting NF-κB and suppressing CCR7/CCL19/CCL21. International Journal of Molecular Medicine. 38(5). 1541–1548. 56 indexed citations
16.
Wei, Ying, Mihui Li, Qingli Luo, et al.. (2016). Loki zupa (Luooukezupa) decoction reduced airway inflammation in an OVA-induced asthma mouse model. Chinese Medicine. 11(1). 22–22. 21 indexed citations
17.
Wei, Ying, Jiaqi Liu, Hongying Zhang, et al.. (2016). Ligustrazine attenuates inflammation and the associated chemokines and receptors in ovalbumine-induced mouse asthma model. Environmental Toxicology and Pharmacology. 46. 55–61. 27 indexed citations
18.
Wei, Ying, Mihui Li, Qingli Luo, et al.. (2014). Comparison of effect of granules and herbs of Bu-Shen-Yi-Qi-Tang on airway inflammation in asthmatic mice. Chinese Medical Journal. 127(22). 3957–3962. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026